302 related articles for article (PubMed ID: 11257017)
1. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
[TBL] [Abstract][Full Text] [Related]
2. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
Chen SH
Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
11. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine therapy of WHV-infected woodchucks.
Mason WS; Cullen J; Moraleda G; Saputelli J; Aldrich CE; Miller DS; Tennant B; Frick L; Averett D; Condreay LD; Jilbert AR
Virology; 1998 May; 245(1):18-32. PubMed ID: 9614864
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus.
Moraleda G; Saputelli J; Aldrich CE; Averett D; Condreay L; Mason WS
J Virol; 1997 Dec; 71(12):9392-9. PubMed ID: 9371599
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
[TBL] [Abstract][Full Text] [Related]
15. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.
Colonno RJ; Genovesi EV; Medina I; Lamb L; Durham SK; Huang ML; Corey L; Littlejohn M; Locarnini S; Tennant BC; Rose B; Clark JM
J Infect Dis; 2001 Nov; 184(10):1236-45. PubMed ID: 11679911
[TBL] [Abstract][Full Text] [Related]
16. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
Zhou T; Guo JT; Nunes FA; Molnar-Kimber KL; Wilson JM; Aldrich CE; Saputelli J; Litwin S; Condreay LD; Seeger C; Mason WS
J Virol; 2000 Dec; 74(24):11754-63. PubMed ID: 11090175
[TBL] [Abstract][Full Text] [Related]
18. Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection.
Freitas N; Lukash T; Rodrigues L; Litwin S; Kallakury BV; Menne S; Gudima SO
J Virol; 2015 Sep; 89(17):8749-63. PubMed ID: 26063428
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
Zhu Y; Cullen JM; Aldrich CE; Saputelli J; Miller D; Seeger C; Mason WS; Jilbert AR
Virology; 2004 Sep; 327(1):26-40. PubMed ID: 15327895
[TBL] [Abstract][Full Text] [Related]
20. Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Volz T; Lütgehetmann M; Allweiss L; Warlich M; Bierwolf J; Pollok JM; Petersen J; Matthes E; Dandri M
Antivir Ther; 2012; 17(4):623-31. PubMed ID: 22368233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
